Literature DB >> 22331869

Progress in breast cancer research.

Kornelia Polyak1, Peter K Vogt.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22331869      PMCID： PMC3286956          DOI： 10.1073/pnas.1201091109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  31 in total

Review 1.  Leukocytes in mammary development and cancer.

Authors:  Lisa M Coussens; Jeffrey W Pollard
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

2.  Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.

Authors:  David G DeNardo; Donal J Brennan; Elton Rexhepaj; Brian Ruffell; Stephen L Shiao; Stephen F Madden; William M Gallagher; Nikhil Wadhwani; Scott D Keil; Sharfaa A Junaid; Hope S Rugo; E Shelley Hwang; Karin Jirström; Brian L West; Lisa M Coussens
Journal:  Cancer Discov       Date:  2011-06-01       Impact factor: 39.397

3.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

4.  Heterogeneity in breast cancer.

Authors:  Kornelia Polyak
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

Review 5.  Targeted therapies for breast cancer.

Authors:  Michaela J Higgins; José Baselga
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

Review 6.  Mechanisms of endocrine resistance in breast cancer.

Authors:  C Kent Osborne; Rachel Schiff
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

7.  Promotion of direct reprogramming by transformation-deficient Myc.

Authors:  Masato Nakagawa; Nanako Takizawa; Megumi Narita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

Review 8.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

9.  AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity.

Authors:  Sarat Chandarlapaty; Ayana Sawai; Maurizio Scaltriti; Vanessa Rodrik-Outmezguine; Olivera Grbovic-Huezo; Violeta Serra; Pradip K Majumder; Jose Baselga; Neal Rosen
Journal:  Cancer Cell       Date:  2011-01-06       Impact factor: 31.743

10.  PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer.

Authors:  V Serra; M Scaltriti; L Prudkin; P J A Eichhorn; Y H Ibrahim; S Chandarlapaty; B Markman; O Rodriguez; M Guzman; S Rodriguez; M Gili; M Russillo; J L Parra; S Singh; J Arribas; N Rosen; J Baselga
Journal:  Oncogene       Date:  2011-01-31       Impact factor: 9.867
View more
  6 in total

1.  CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression.

Authors:  Amlan Das; Inamul Haque; Priyanka Ray; Arnab Ghosh; Debasmita Dutta; Mohiuddin Quadir; Archana De; Sumedha Gunewardena; Indranil Chatterjee; Snigdha Banerjee; Scott Weir; Sushanta K Banerjee
Journal:  Pharmacol Res Perspect       Date:  2021-04

2.  Metal-Arene Complexes with Indolo[3,2-c]-quinolines: Effects of Ruthenium vs Osmium and Modifications of the Lactam Unit on Intermolecular Interactions, Anticancer Activity, Cell Cycle, and Cellular Accumulation.

Authors:  Lukas K Filak; Simone Göschl; Petra Heffeter; Katia Ghannadzadeh Samper; Alexander E Egger; Michael A Jakupec; Bernhard K Keppler; Walter Berger; Vladimir B Arion
Journal:  Organometallics       Date:  2013-01-17       Impact factor: 3.876

3.  The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors.

Authors:  Elodie Chantalat; Frédéric Boudou; Henrik Laurell; Gaëlle Palierne; René Houtman; Diana Melchers; Philippe Rochaix; Thomas Filleron; Alexandre Stella; Odile Burlet-Schiltz; Anne Brouchet; Gilles Flouriot; Raphaël Métivier; Jean-François Arnal; Coralie Fontaine; Françoise Lenfant
Journal:  Breast Cancer Res       Date:  2016-12-07       Impact factor: 6.466

Review 4.  Estrogen receptor-α signaling in post-natal mammary development and breast cancers.

Authors:  Marine Adlanmérini; Elodie Chantalat; Mariam Rusidzé; I Raymond-Letron; Surya Cayre; Jean-François Arnal; Marie-Ange Deugnier; Françoise Lenfant
Journal:  Cell Mol Life Sci       Date:  2021-06-22       Impact factor: 9.261

5.  Clinical Application of Computer-Aided Diagnosis for Breast Ultrasonography: Factors That Lead to Discordant Results in Radial and Antiradial Planes.

Authors:  Ying Zhu; Weiwei Zhan; Xiaohong Jia; Juan Liu; Jianqiao Zhou
Journal:  Cancer Manag Res       Date:  2022-02-23       Impact factor: 3.989

Review 6.  Understanding breast cancer stem cell heterogeneity: time to move on to a new research paradigm.

Authors:  Ferdinando Mannello
Journal:  BMC Med       Date:  2013-07-23       Impact factor: 8.775
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.